Prognostic significance and clinical determinants of residual dyspnoea at discharge in acute heart failure: a single-centre, prospective observational study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 37984947.
- Also identified by DOI 10.1136/bmjopen-2023-075302 and PMC identifier 10661057.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to assess the prognostic significance of residual (discharge) dyspnoea in acute heart failure (AHF) patients. Single-centre, prospective observational study. Patients hospitalised for decompensated AHF in a single cardiology centre, in Poland. All patients (n=202) who survived the hospitalisation with the primary diagnosis of AHF and were discharged from the hospital. 1-year all-cause mortality; and the composite endpoint of 1-year all-cause mortality and rehospitalisation for the HF (whichever occurred first). On admission, 159 (78.7%) AHF patients presented dyspnoea at rest, while residual resting dyspnoea at discharge was present in 16 patients (7.9%). There were 48 (24%) patients with moderate/severe exertional dyspnoea at discharge. In the multivariable model, the resting dyspnoea at discharge was related to a higher risk of both 1-year mortality and composite outcome, with HR (95% CI) 8.0 (3.7 to 17.3) and 5.1 (2.6 to 10.2), respectively, both p<0.0001. Analogically, moderate or severe residual dyspnoea at discharge was related to the heightened risk of study both outcomes, with HR (95% CI) 3.1 (1.8 to 5.4) and 1.8 (1.1 to 2.9), respectively, p<0.01. Among AHF patients the residual dyspnoea at discharge was unexpectedly common and was associated with an unfavourable outcome during 1-year follow-up.
Medical subject headings
- Patient Discharge
- Heart Failure